Cefdinir: An oral alternative to parenteral cephems
- 30 April 2005
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 51 (4), 259-264
- https://doi.org/10.1016/j.diagmicrobio.2004.11.015
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance ProgramDiagnostic Microbiology and Infectious Disease, 2003
- Reactive Metabolites and Adverse Drug Reactions: Clinical ConsiderationsClinical Reviews in Allergy & Immunology, 2003
- Cefdinir: An advanced-generation, broad-spectrum oral cephalosporinClinical Therapeutics, 2002
- Pharmacodynamics and pharmacokinetics of cefdinir, an oral extended spectrum cephalosporinThe Pediatric Infectious Disease Journal, 2000
- Cefdinir: An Expanded-Spectrum Oral CephalosporinAnnals of Pharmacotherapy, 2000
- Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infectionClinical Therapeutics, 2000
- Comparison of cefdinir and penicillin for the treatment of pediatric streptococcal pharyngitisClinical Therapeutics, 1999
- Epidemiology and Successful Control of a Large Outbreak Due to Klebsiella pneumoniae Producing ExtendedSpectrum β-LactamasesAntimicrobial Agents and Chemotherapy, 1998
- Clinical and Economic Considerations in the Use of Third-Generation Oral CephalosporinsPharmacoEconomics, 1995
- Stability of cefdinir (CI-983, FK482) to extendedspectrum plasmid-mediated -lactamasesJournal of Medical Microbiology, 1993